RABIES (HEALTHY VOLUNTEERS)
Clinical trials for RABIES (HEALTHY VOLUNTEERS) explained in plain language.
Never miss a new study
Get alerted when new RABIES (HEALTHY VOLUNTEERS) trials appear
Sign up with your email to follow new studies for RABIES (HEALTHY VOLUNTEERS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New rabies vaccine shows promise in thai trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new rabies vaccine (VRVg) in 403 healthy volunteers in Thailand. The goal was to see if the vaccine triggers a strong immune response when given in two different injection schedules after a pretend rabies exposure. Some adults also received rabies antibodies (…
Matched conditions: RABIES (HEALTHY VOLUNTEERS)
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 11:41 UTC
-
New rabies vaccine shows promise in large trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new rabies vaccine in over 2,000 healthy people aged 10 to 60. The goal was to see how well different vaccination schedules work and if they are safe compared to an existing vaccine. Results help improve protection after a rabies exposure.
Matched conditions: RABIES (HEALTHY VOLUNTEERS)
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:53 UTC
-
New rabies vaccine shows promise in thai study
Prevention CompletedThis study tested a new rabies vaccine (VRVg) in 201 healthy adults in Thailand. The goal was to see if it works as well as the current vaccine when given after a possible rabies exposure. Participants received the vaccine along with rabies antibodies, and researchers measured th…
Matched conditions: RABIES (HEALTHY VOLUNTEERS)
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated May 26, 2026 11:42 UTC
-
New rabies vaccine passes major test in healthy adults
Prevention CompletedThis study tested a new rabies vaccine (VRVg-2) in 640 healthy adults to see if it works as well as current vaccines when given after a possible rabies exposure. Participants received the vaccine along with rabies antibodies. The results showed the new vaccine produced a strong i…
Matched conditions: RABIES (HEALTHY VOLUNTEERS)
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated May 18, 2026 12:04 UTC